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MANUSCRIPT: “Effect of antipsychotics on mitochondrial bioenergetics of rat ovarian theca 
cells” 
Highlights: 
 This study investigated the effects of four antipsychotics (APs) on mitochondrial bioenergetics and 
steroidogenesis of rats isolated ovarian theca interstitial cells (TICs) as a possible mechanism of 
reproductive toxicity.   
 The APs used in this experiment include chlorpromazine (CPZ) haloperidol (HAL), risperidone (RIS) 
clozapine (CLZ).  
 All four APs seem to inhibit mitochondrial bioenergetics and steroidogenesis in rat’s TICs.  
 These findings support the hypothesis that APs-induced reproductive toxicity may be through 
mechanisms involving mitochondrial insult.  
  
Abstract: 
Background: Antipsychotics (APs) are widely prescribed drugs, which are well known to cause 
reproductive adverse effects through mechanisms yet to be determined. The purpose of this study 
was to investigate the effect of antipsychotics on mitochondrial bioenergetics of rat ovarian theca 
cells as a possible mechanism of reproductive toxicity. Methods: Isolated rat’s theca interstitial 
cells (TICs) were treated with two typical (chlorpromazine [CPZ] and haloperidol [HAL]) and two 
atypical APs (risperidone [RIS] and clozapine [CLZ]). The effects of these APs on TICs 
bioenergetics (ATP content, mitochondrial complexes I and III activities, oxygen consumption 
rates (OCRs), mitochondrial membrane potential (MPP) and lactate production) and on 
steroidogenesis (androstenedione and progesterone synthesis) were investigated. Results: All APs 
resulted in a concentration-dependent decrease in the ATP content of TICs. All APs in their 
estimated IC50s (6 µM, 21 µM, 35 µM and 37µM for CPZ, HAL, CLZ and RIS respectively) 
significantly decreased TICs OCRs (p<0.0001), MPP (p<0.0001) and significantly (p =0.0003) 
inhibited mitochondrial complex I activity. Only typical APs inhibited complex III (p=0.005). 
Also, APs in IC50s increased TICs lactate production to varying degrees. All APs used at their 
IC50s significantly inhibited progesterone (p=0.0022) and androstenedione (p=0.0027) production. 
Only CPZ was found to inhibit these hormones in the low concentration (1µM). Conclusion: All 
four antipsychotics seem to inhibit mitochondrial bioenergetics and steroidogenesis in rat’s ovarian 
theca cells. These findings support the hypothesis that APs-induced reproductive toxicity may be 
through mechanisms involving mitochondrial insult. Further research is required to establish the 
link between APs-induced mitochondrial dysfunction and disordered steroidogenesis. 
Keywords: Antipsychotics; ; ; , Ovarian cytotoxicity, Mitochondrial bioenergetics, Reproductive 
toxicity 
INTRODUCTION 
Antipsychotics (APs) are well known for their toxicity, which affects almost all systems of the 
body resulting in a wide range of manifestations such as extra-pyramidal symptoms, weight gain 
and reproductive dysfunction. Chlorpromazine (CPZ) has been shown to inhibit ovulation in rats 
via suppression of the LH surge (Everett and Taya, 1982). Haloperidol (HAL) has been shown to 
lower ovarian and uterine weights and to inhibit ovulation in rats (Boris et al., 1997). 
Antipsychotic-induced hyperprolactinaemia has been strongly suggested as a mechanism for these 
reproductive dysfunctions. Several studies have reported an association between 
hyperprolactinaemia and reproductive dysfunction in women receiving APs (Ghadirian et al., 
1982; Meltzer, 1985; Bargiota et al., 2013). However, other studies reported no association 
between hyperprolactinaemia and reproductive dysfunction during AP therapy (Canuso et al, 
2002). Therefore, the mechanisms explaining the reproductive adverse effects of APs remain 
largely uncertain. 
Several APs, such as haloperidol (HAL), chlorpromazine (CPZ), thiothixine and clozapine (CLZ), 
have been found to inhibit mitochondrial respiratory enzyme complexes, which have a crucial role 
in Oxidative phosphorylation cycle for the synthesis of adenosine triphosphates (ATP) (Burkhardt 
et al, 1993). Inhibited respiratory enzyme complexes have been found to induce damage to the 
mitochondria via the release of reactive oxygen species (ROS) (Wei et al., 1998 and Harper et al., 
2004, Guo et al., 2013). This mitochondrial damage has been suggested as a possible mechanism 
of AP-induced extrapyramidal side effects such as tardive dyskinesia (Goff et al., 1995 and 
Casademont et al., 2007). This hypothesis, which is widely accepted, has been supported by several 
studies reporting a correlation between the tardive dyskinesia and mitochondrial inhibition during 
APs treatment and production of ROS  (Grenell  et  al,  1955;  Guth  et  al,  1964;  Gallagher  et  
al,  1965, Elkashef and  Wyatt, 1999).  
In this study, we hypothesized that mitochondrial dysfunction is the underlying mechanism of AP-
induced reproductive adverse effects. Ovarian theca interstitial cells (TICs) were isolated from rats 
and used as a cell model to test the effects of APs. The primary aim of this study was to investigate 
the cellular and functional effects of two typical APs (haloperidol [HAL], chlorpromazine [CPZ)]) 
and two atypical APs (risperidone [RIS] and clozapine [CLZ]) on mitochondrial bioenergetics and 
on steroidogenesis of rat’s TICs.  
MATERIALS 
Chemicals and media 
All chemicals and reagents including the APs were purchased from Sigma-Aldrich (Poole, UK) 
unless stated otherwise. Two typical (CPZ and HAL) and two atypical (RIS and CLZ) APs were 
obtained for this study. All stock solutions of drugs were made in DMSO (vehicle) then diluted 
further in media as required. Media and their additives were purchased from Gibco (Grand Island, 
NY). The adenosine triphosphate (ATP) assay and lactate colorimetric assay kits were purchased 
from Abcam (Cambridge, MA, USA).  
Animals 
Female Sprague-Dawley rats were used. They were provided with water and rat chow ad libitum 
and housed in air-conditioned rooms that were illuminated 14 h/day. The experiments were carried 
out in accordance with the principles and guidelines for the use of laboratory animals and approved 
by the institutional research animal committee, Mansoura University, Egypt. 
Theca interstitial cells isolation and culture 
In order to obtain rat pre-ovulatory follicles, immature 23- to 24-day-old female rats were injected 
with equine chorionic gonadotropin (eCG) (10 IU) between 09:00 and 09:30 h to enhance multiple 
follicular development. The rats were then anaesthetized and TICs were isolated according the 
method described by Hoang et al (2013). Briefly, ovaries were removed and follicles were 
punctured with needles to release granulosa cells (GCs) and oocysts. The remaining ovarian tissue 
was minced with a scalpel and digested in 100 μL/ovary of M199 medium with 0.35 mg/mL 
collagenase type IA, 10 ug/mL DNase, and 10 mg/mL BSA at 37oC for 30 minutes. After digestion, 
the tissue was centrifuged at 1,000 rpm for 4 minutes then the media was aspirated, and cells were 
resuspended in 5 mL fresh M199. Debris and oocytes were subsequently removed using 100- and 
40-mm cell strainers.  
Theca cell purification was performed according to the methods described by Magoffin and 
Erickson (1988). Discontinuous Percoll gradients were formed using both 36% and 50% percoll 
solutions. Theca cells were separated in the interface between the two Percoll layers and aspirated 
using a 20-gauge needle and syringe. The isolated cells were then washed twice in M199 and 
resuspended in Hepes-buffered medium 199 with 5% FCS for 24 h, followed by 24–48 h in serum-
free media containing 0.1% BSA.  The primary TICs were cultured in individual wells of 24-well 
culture plates (4x105/ well) (Falcon, Meylan Cedex, France), in 5% CO2/air atmosphere and 
maintained at 37˚C.  
METHODS 
Intracellular adenosine triphosphate (ATP) content 
Intracellular ATP was measured using Abcam assay kit according to the manufacturer’s protocol.  
Briefly, cells (36x103) were seeded in each individual well of a 96-well plate. After overnight 
incubation, cells were treated with the test APs in concentrations 0.1, 1, 10 and 100µM for 24 hrs. 
Afterward, 50 µl of cell lysis buffer containing an inhibitor of ATPase was added to each well, 
and the plate was shaken gently for 5 minutes. Then the 50 µl reconstituted substrate was added to 
each well and the plate shaken again for another 5 minutes and kept in dark for 10 minutes before 
measurements. The amounts of ATP were measured with a microplate scintillation counter 
‘TopCount’ (Perkin Elmer, Ueberlingen, Germany) enabling quantitative measurements via 
luminescence detected by single photon counting. Basal values in the medium were subtracted 
from each reading obtained in the presence of test drug then viability was expressed as a percentage 
from the same concentration of the vehicle control readings, presuming that the vehicle control 
viability is 100%. 
Effect of APs on TICs oxygen consumption rates (OCRs) 
TICs were incubated with the vehicle and with inhibitory concentrations 50 (IC50s, defined as the 
concentration that inhibits up to 50% of the viability of control cells) and 1µM of the APs for 24 
hrs. Then cells were harvested by trypsinization, centrifuged and re-suspended in Hank’s solution 
[that contained (in mM): 5.6 KCl, 138 NaCl, 4.2 NaHCO3, 1.2 NaH2PO4, 2.6 CaCl2, 1.2 MgCl2, 
10 HEPES (pH 7.4 with NaOH), and 0.1% (wt/vol) BSA] and counted by haemocytometer. Then 
oxygen consumption rats (OCR) were assessed polarographically using Clark oxygen electrodes 
(Rank Brothers). Firstly, OCRs were studied in the basal condition for 10 minutes then 2µL of 
6mM azide solutions were added to each chamber. OCR was measured as the change in oxygen 
tension level over a 300-sec period.  In all OCR experiments; subsequent application of 6 mm 
azide, a blocker of cytochrome oxidase, partly blocked cells O2 consumption. This confirms that 
the majority of O2 consumption measured reflects mitochondrial respiration. Also the TICs’ 
response to azide confirms absence of cellular damage due to stirring. For glucose, the slope was 
measured 120 seconds after reagent addition, whereas for azide, the slope was measured 60 
seconds after its addition. 
Effect of APs on TICs Mitochondrial membrane potential (MPP) 
To monitor the changes in TICs MMP we used rhodamine-123 (Rh-123) which is a well-
established cationic lipophilic dye with high affinity to be localized to mitochondria. 
Depolarization of mitochondrial membranes, caused by uncoupling or blocking of mitochondrial 
respiration, results in redistribution of the dye with less amount retained inside the cells and 
increased measured fluorescence outside the cells and vice versa with increased hyperpolarization 
of the mitochondrial membranes (Duchen et al., 1993; Baracca et al., 2003). Briefly, TICs were 
treated with APs in both 1µM and IC50s. After 24 hrs cells were harvested and counted. Then cells 
were loaded with 50µg/ml Rh-123 in Hank’s solution (same constitutes as Hank’s solution used 
for OCR) at 37oC in a quartz cuvette in a spectrophotometer (Hitachi) for 3 minutes. After 3 
minutes Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) (1µM) was added for 
each cuvette to confirm the functional integrity of the cells.  The dye was excited at 480 nm and 
the emitted fluorescence monitored at 530 nm. Fluorescence was normalized to the number of 
cells.  
Effect of APs on mitochondrial complexes 
TICs were seeded in T75 flasks till confluence, then treated with the test APs, used at the IC50 
concentration for 24 hrs. Complexes were then assayed using TIC mitochondrial enriched fraction 
for complex I and TIC lysate for complex III. Both mitochondrial enriched fraction and cell lysates 
were prepared following methods described by Spinazzi et al. (2012). For complex I assay, 
Dichlorophenolindophenol (DCIP) was used as a terminal electron acceptor (Janssen et al., 2007). 
Complex I oxidizes NADH, and the electrons produced reduce the artificial substrate 
decylubiquinone that subsequently delivers the electrons to DCIP.  Complex III activities were 
studied as previously described by Spinazzi et al. (2012). 
Lactate production assay 
TICs were seeded in 24-well plates and treated with IC50 of the test APs. The supernatant media 
were collected and assayed immediately for lactate levels using glucose assay kit and lactate assay 
kit according to the manufacturer’s instruction. Lactate production was normalized to cell number 
and expressed as a percentage of control lactate production. All experiments were performed in 
triplicate (i.e. three wells of each concentration in each experiment) and repeated three times. 
Effect of APs on progesterone and androstenedione secretion 
TICs were incubated with APs at both estimated IC50s and 1µM for 24hrs. Enzyme linked 
immunosorbent assay (ELISA) was used to measure progesterone and androstenedione in the 
media obtained from the cultured TICs before and after treatment with the APs. For progesterone 
assay, progesterone ELISA kit was purchased from (Enzo Life Sciences) with sensitivity down to 
8.57 pg/ml. The results were read at Absorbance of 405 nm. While for androstenedione assay, the 
kit was obtained from Aviva Systems Biology with detection range of 0.312 - 20 ng/mL  and 405 
nm was used as the accurate absorbance to read the results.  
Statistical analysis 
Statistical analysis was performed using Prism V6 6 (GraphPad Software Inc., San Diego, CA). 
Data did not show normal distribution by as determined by D'Agostino–Pearson omnibus 
normality test. We therefore used Kruskall Wallis test with Dunn’s multiple comparisons post-test 
to compare multiple treatments. The (IC50) for each AP was quantified by fitting the data with the 
log(inhibitor) versus response -variable slope equation is Prism V6. 
RESULTS 
Antipsychotics and TIC viability 
Intracellular ATP assay showed concentration-dependent decrease in TICs intracellular ATP 
concentration after 24-hr treatment with the four tested APs (figure 1A).  The estimated IC50s for 
the studied APs were 6, 21, 35 and 37µM for CPZ, HAL, CLZ and RIS respectively (24 hours 
post-treatment). According to these values, CPZ was the most potent, while RIS was the least toxic 
with the highest IC50 (figure 1B). 
Antipsychotics decreased TICs oxygen consumption rates (OCRs) 
All APs significantly (p<0.0001) decreased TICs’ basal OCRs, as shown in figure (2A), by 
56.3±14.4% (p<0.001), 34.5±12.5% (p<0.01), 36±13.5 (p<0.01) and 26.2±17.6% (p<0.05) for 
CPZ, HAL, CLZ and RIS respectively in their IC50s. None of the APs in a concentration of 1µM 
had any statistically significant effect on TICs’ OCRs (Figure 2B).  
Antipsychotics and MMP 
Figure 2C shows significant (p<0.0001) increase in Rhodamine-123 (Rh-123) in TICs treated with 
all APs (used at their IC50s). This signifies a decrease in TICs’ mitochondrial membrane potential. 
However, all APs had no significant effect on MMP of TICs in 1µM concentration (figure 2D). 
Antipsychotics and mitochondrial complexes I and III functions 
As shown in figure 3A, all tested APs used at their IC50s significantly (p<0.0001) inhibited 
mitochondrial complex I activities. CPZ was the most potent, while CLZ was the least potent. With 
regards to mitochondrial complex III, only the typical preparations (CPZ and HAL) showed 
significant inhibitory effects (Fig 3B). On the other hand, only CPZ in 1µM concentration 
significantly (p=0.032) inhibited complex I. 
APs and TICs lactate production 
As shown in figure 3C, all APs at IC50s significantly (p< 0.001) increased TIC lactate production 
to different extents, with typical APs having more potent effects. On the other hand APs used at  
10µM concentration had no statistically significant (p=0.67) effect on cellular lactate production.  
Antipsychotics and TIC production of progesterone and androstenedione 
As illustrated in figure 4, ELISA showed that all the tested APs at the IC50 concentration 
significantly lowered TICs’ secretion of both progesterone and Androstenedione to different 
extents. CPZ showed the most potent inhibitory effect on progesterone secretion. In addition, 
typical APs (CPZ and HAL) showed a greater inhibitory effect on androgen productions compared 
to the newer atypical APs (RIS and CLZ). Only CPZ in a concentration of 1µM showed significant 
inhibitory effect of TIC secretory functions.  
DISCUSSION 
To the best of our knowledge, this is the first study to investigate the effects of antipsychotics 
(APs) on ovarian theca mitochondrial bioenergetics and steroidogenesis as possible mechanisms 
of reproductive toxicity. We found that APs impaired viability of rat’s TICs in a concentration 
dependent manner, decreased TIC OCR, decreased mitochondrial membrane potential, inhibited 
mitochondrial complexes I and III activities, increased TICs lactate production and lowered TICs 
secretion of both progesterone and androstenedione. 
The rat was chosen as a model for this study as it is relatively easy to isolate and culture theca cells 
from its ovaries. In addition, it has been shown to be a valuable in-vitro model for evaluating the 
safety of chemicals (Roberts, 2001). Theca interstitial cells (TICs) were used as they have an 
important role in ovarian steroidogenesis (Young and McNeilly, 2010). In addition, TICs’ 
mitochondria have been found to play a crucial role in steroidogenesis as they convert cholesterol 
to pregnenolone (Miller, 2013). They also determine the net steroidogenic capacity of TICs thereby 
serving as chronic regulators of steroidogenesis (Miller, 2013). Theca cell mitochondrial damage 
will therefore affect steroidogenesis with subsequent reproductive dysfunction. 
We investigated the effects of a wide range of AP concentrations (0.1, 1, 10 and 100µM) on 
intracellular ATP content. These concentrations correspond to therapeutic, hyper-therapeutic and 
toxic APs levels seen in human (Winek et al., 2001; Van Putten et al.,1991; Chang et al., 1997; 
Chang et al., 1994). Therapeutic serum levels were previously reported as 0.01-0.5 mg/l (0.03-1.5 
µM) for CPZ, 0.1-0.7 mg/l  (0.3–2µM) for CLZ, 0.006-0.24 mg/l (0.016-0.64 µM) for  HAL and 
0.003-0.12 mg/l (0.007–0.28 µM) for RIS (Winek et al., 2001). On the other hand, overdose serum 
levels were reported as 3mM for CPZ (Van Putten et al.,1991), 5mM for CLZ (Chang et al., 1997), 
0.7mM for HAL (Chang et al., 1994) and for RIS 0.5–0.8mM (220 to 320 ng/mL ng/ml; Titier et 
al., 2003; Nishikage et al., 2002). Higher concentrations were used to accelerate the effects of the 
APs on the TIC of the rats’ ovaries.  
The present study showed that APs decreased the intracellular contents of ATP in rat TICs. CPZ 
was the most toxic with the lowest IC50 followed by CLZ, whereas, HAL and RIS had less 
cytotoxic effects. This finding is not consistent with the general believe that typical APs are more 
cytotoxic than the atypical ones. However, recent research has revealed HAL, which is a typical 
AP to be less cytotoxic than CLZ metabolite (desmethyle CLZ), which is an atypical AP (Donard 
et al., 2003). Other studies however showed HAL to have a more potent neurotoxic due to its 
metabolite (Subramanyam et al., 1991; Burkhardt et al., 1993, Raudenska et al., 2013). 
The present data on TICs’ ATP are in agreement with several previous in-vivo and in vitro-studies 
investigating non-reproductive cells. Vairetti, et al. (1999) reported significantly decreased ATP 
contents in the cerebellum, striatum and cortex of HAL-treated rats. Heiser, et al. (2007) also found 
significantly decreased ATP levels in SH-SY5Y and in U-973 cell lines after treatment with HAL. 
On the other hand, CLZ and olanzapine showed no effect on ATP levels of these cell lines. 
Furthermore, our group has previously reported that CPZ, HAL, CLZ and RIS significantly 
decreased ATP production in brain microvascular cells in concentrations and exposure durations 
dependent manner (Elmorsy and Smith, 2015). 
Our data on the effects of APs on TICs mitochondrial OCR are in agreement with the previous 
studies investigating the effect of APs on mitochondrial OCRs of non-reproductive cells. Nagads 
(1992) reported that CPZ in 0.1 mM increased sperms OCRs, but CPZ in 0.75mM decreased 
sperms OCRs. Modica-Napolitano et al. (2003) reported that that CPZ at a concentration of 100 
µM increased OCR (4-5 folds) in isolated mitochondria from non-reproductive cells. On the other 
hand, they showed ClZ, RIS, QTN and OLZ to have no effect on OCRs. Ishikawa et al. (2006) 
showed that HAL in a low concentration (10µg/mL) decreased OCRs of neuronal and myocardial 
cell lines.  
Regarding Rh-123 assay, our results are similar to previous studies investigating the effects of APs 
on MMP in non-reproductive cells. Several APs (CPZ, HAL, RIS and CLZ) have been shown to 
decrease the mitochondrial trans-membrane potential (Neustadt and Pieczenik, 2008, Elmorsy and 
Smith, 2015). Furthermore, Donohoe et al., (2006) showed APs to have an affect on the Calcium- 
calmodulin system, which is known to affect the mitochondrial membrane potential and ATP 
synthesis. 
The present data regarding the effect of APs on TICs mitochondrial complexes are in agreement 
with other published articles on non-reproductive cells. An in-vitro study by Burkhardt et al. 
(1993) found that APs inhibited mitochondrial complex I. In addition, other studies found that 
injecting mice with different APs (HAL, CLZ and RIS) led to inhibition of complex I activity in 
different parts of the brain after a variable length of time (Balijepalli et al., 2001; Karry et al,. 
2004). Furthermore, Casademont et al. (2007) reported that HAL, RIS and CLZ could inhibit 
mitochondrial complex I.  
It is clear from our data that all tested APs increased lactate production of TICs. This could be 
explained by the inhibitory effects of the APs on mitochondrial complexes and membrane potential 
resulting in inhibition of oxidative phosphorylation of glucose. This in turn will result in shift of 
the cells to glycolysis to maintain their energy requirements, thereby increasing the production of 
lactate. Our results are in agreement with in-vivo human studies. Glavina et al. (2011) reported 
that APs increased serum lactate level in patients receiving treatment with HAL and olanzapine 
(atypical AP). The study has also showed correlation between serum lactate levels and incidence 
of AP-induced extra-pyramidal side effects.  
Our observations on the effects of APs on theca cell mitochondrial bioenergetics are important for 
several reasons. Firstly, the potency of the AP in compromising mitochondrial functions seems to 
correlate with the likelihood and severity of its side effects in humans. This is evidenced by the 
greater potency of typical APs (on mitochondrial functions), which are also known to cause greater 
side effects in humans compared to the typical ones. This suggests that the methods used in this 
study could be used to test the degree of toxicity of any newly developed APs. Secondly, the 
consistency of our data with previous in-vivo and in-vitro studies examining the effects of APs on 
mitochondrial function suggest that the mechanisms of oxidative phosphorylation are "generic" to 
mammalian mitochondria. Thirdly, our results suggest that a respiratory substrate (such as 
hydroxybutyrate) or vitamin (such as coenzyme Q) could potentially be used clinically to 
overcome the inhibitory effects of APs on mitochondrial complexes, thereby potentially reducing 
the side effects and improving their tolerability. However, this hypothesis will need to be further 
investigated in future research. Finally, these data also suggest a role for serum lactate 
measurement as an early clinical biomarker for safety screening of the newly discovered APs.  
In conclusion, APs seem to inhibit theca cell mitochondrial bioenergetics as well as 
steroidogenesis. These data support the hypothesis that the damaging effect of APs on TICs 
mitochondria could be the mechanism of APs-induced reproductive toxicity. However, the link 
between APs-induced mitochondrial and steroidogenic dysfunctions remains to be investigated.  
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Figures legends: 
Figure 1: The effects of APs on ATP content in TICs: (A) Intracellular TICs ATP content 
expressed as a percentage of the vehicle control. Data presented as means ± S.E.M. Solid lines 
have been fitted to the log (inhibitor) versus response-variable slope equation. B) estimated IC50s 
of the four APs. IC50s were estimated from the best fit of data with 95% confidence intervals. Data 
shown as mean ± 95% confidence interval. 
 CPZ = chlorpromazine; HAL = Haloperidol;  CLZ = Clozapine;  RIS = risperidone 
Figure 2: The effect of APs on oxygen consumption rates (OCRs) and mitochondrial 
membrane potential (MPP) of TICs. Data shown as mean ± SD. P-values showed in the graph 
were calculated by Dunn’s post-test. (* indicates p-value <0.05, ** indicate p-value <0.01, and 
*** indicate p < 0.001 when compared with vehicle control treated group. 
Figure 3: The effect of APs in their IC50 and 1µM on TIC mitochondrial complexes I and III 
and on lactate production. Data expressed as a percentage of vehicle control. Readings for 
complexes activities of the treated samples was compared statistically with the vehicle samples. 
P-values showed in the graph were calculated by Dunn’s post-test. (* indicates p-value <0.05, ** 
indicate p-value <0.01, and *** indicate p < 0.001 when compared with vehicle control treated 
group). 
Figure 4: The effect of 24-hr incubation with APs on TICs steroidogenesis. A) the effect of 
APs in their IC50 on TICs progesterone secretion. B) the effect of the APs at 1 M on TICs 
progesterone secretion. C) the effect of APs used at the IC50 on TICs androstenedione secretion. 
D) the effect of APs used at 1 M on TICs androstenedione secretion. P-values showed in the 
graph were calculated by Dunn’s post-test.* indicates p-value <0.05, ** indicate p-value <0.01, 
and *** indicate p < 0.001 compared to vehicle control treated group 
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